Archives
- 2025-11
 - 2025-10
 - 2025-09
 - 2025-03
 - 2025-02
 - 2025-01
 - 2024-12
 - 2024-11
 - 2024-10
 - 2024-09
 - 2024-08
 - 2024-07
 - 2024-06
 - 2024-05
 - 2024-04
 - 2024-03
 - 2024-02
 - 2024-01
 - 2023-12
 - 2023-11
 - 2023-10
 - 2023-09
 - 2023-08
 - 2023-07
 - 2023-06
 - 2023-05
 - 2023-04
 - 2023-03
 - 2023-02
 - 2023-01
 - 2022-12
 - 2022-11
 - 2022-10
 - 2022-09
 - 2022-08
 - 2022-07
 - 2022-06
 - 2022-05
 - 2022-04
 - 2022-03
 - 2022-02
 - 2022-01
 - 2021-12
 - 2021-11
 - 2021-10
 - 2021-09
 - 2021-08
 - 2021-07
 - 2021-06
 - 2021-05
 - 2021-04
 - 2021-03
 - 2021-02
 - 2021-01
 - 2020-12
 - 2020-11
 - 2020-10
 - 2020-09
 - 2020-08
 - 2020-07
 - 2020-06
 - 2020-05
 - 2020-04
 - 2020-03
 - 2020-02
 - 2020-01
 - 2019-12
 - 2019-11
 - 2019-10
 - 2019-09
 - 2019-08
 - 2019-07
 - 2019-06
 - 2019-05
 - 2019-04
 - 2018-07
 
- 
                
          
A promising target that is involved in
2023-02-01

A promising target that is involved in the biosynthesis of the precursor LTA4 is the 5-LO-activating protein (FLAP), which in vivo is seemingly indispensable for LT formation [8], [9]. FLAP, a member of the MAPEG family (membrane-associated proteins in eicosanoid and glutathione metabolism), is an i
 - 
                
          
br There are three types of
2023-02-01

There are three types of 5-HT2 receptors. 5-HT2A, 5-HT2B and 5-HT2C receptors Exhibit 46–50% overall sequence identity and couple preferentially to Gq/11 to increase inositol phosphates and cytosolic [Ca2+] and in agreement with their long known role in muscle contraction and stimulation in the br
 - 
                
          
br Experimental procedure br Introduction Migraine is
2023-02-01

Experimental procedure Introduction Migraine is a debilitating neurovascular disorder characterized by recurring unilateral pulsating headaches of moderate to severe intensity, associated with nausea, photophobia and/or phonophobia, lasting from 4 to 72 h (Headache Classification Committee of
 - 
                
          
Vortioxetine is a multimodal antidepressant
2023-02-01

Vortioxetine is a multimodal antidepressant that acts as an inhibitor at the serotonin (5-HT) transporter (SERT), an agonist at 5-HT1A receptors, a partial agonist at 5-HT1B receptors, and an antagonist at 5-HT1D, 5-HT3 and 5-HT7 receptors (Bang-Andersen et al., 2011, Sanchez et al., 2015). Based on
 - 
                
          
br Conclusion br List of abbreviations br
2023-02-01

Conclusion List of abbreviations Acknowledgment The studies performed by our laboratory and presented in this review were supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, (KAKENHI 17590618 [to H.I.] and KAKENHI 22249017 [to Y.Y.]), and the Japanese S
 - 
                
          
Two major categories of arginase inhibitors have
2023-01-31

Two major categories of arginase inhibitors have been distinguished (Fig. 3): the first category comprises synthetic arginase inhibitors, which have been developed from the substrate l-arginine [35]; and the second category includes inhibitors derived from natural products [36]. The category of synt
 - 
                
          
Here we provide evidence that NO contributes to changes in
2023-01-31

Here, we provide evidence that NO contributes to changes in synaptic strength, but also offer an explanation as to why previous attempts to link NO to LTP have often failed. Our results describe a model by which cycling AMPARs, held in intracellular pools, are rapidly delivered to the membrane surfa
 - 
                
          
The binding of TQ to hsALDH
2023-01-31

The binding of TQ to hsALDH changes the characteristic AEBSF spectrum of the enzyme. Therefore, TQ forms a complex with hsALDH and changes its absorption properties [39]. Ksv and Kb values indicate that the binding of TQ to hsALDH is very strong and of the order of static binding (complex formation
 - 
                
          
alln australia Many of the cellular processes regulated by A
2023-01-31

Many of the cellular processes regulated by AKT activation are also controlled by other intracellular pathways such as the MAPK pathway, the PLCγ pathway, but also, directly or indirectly, by signaling pathways not linked to RTK transmembrane receptors, such as growth factor-linked signaling affecti
 - 
                
          
The central problem in amnesia developing following
2023-01-31

The central problem in amnesia developing following impairment of long-term memory consolidation or reconsolidation is a question of the underlying mechanisms, whether it is caused by impairment of retrieval or memory storage mechanisms [3,8,9,[15], [16], [17], [18]]. To answer this question, severa
 - 
                
          
Pioneering studies on the immunomodulatory role of adenosine
2023-01-31

Pioneering studies on the immunomodulatory role of adenosine date back to the early ‘70 s of last century (Fig. 1), when the critical role of this nucleoside in shaping the development and the activity of several immune cell populations was first established [[18], [19], [20], [21], [22]]. This then
 - 
                
          
The SKOV and SKOV TR cells were exposed to
2023-01-31

The SKOV3 and SKOV3TR Aldicarb were exposed to stepwise increased concentration of paclitaxel with or without a different concentration of autophagy inhibitor (3-MA or HCQ) to further evaluate whether suppression of autophagy affected the growth and drug sensitivity of ovarian cancer cells in vitro
 - 
                
          
Recent findings imply that proper Na K ATPase function is
2023-01-31

Recent findings imply, that proper Na+/K+-ATPase function is crucial for unimpaired development of the vertebrate heart. Targeted knockout of Na+/K+-ATPase α1 in mice led to early embryonic lethality whereas heterozygous knockout mice displayed severe hypocontractile hearts [52]. Pharmacological inh
 - 
                
          
br Regulatory mechanisms of ASK activity br The
2023-01-31

Regulatory mechanisms of ASK1 activity The functions of ASK1 in disease ASK1 inhibitor As mentioned above, ASK1 plays a pivotal role in the pathogenesis of various diseases; hence, an ASK1 inhibitor has therapeutic potential. Although inhibitors of the ASK1 downstream kinases p38 and JNK ar
 - 
                
          
Most of lipid lowering agents have many therapeutic
2023-01-30

Most of lipid-lowering agents have many therapeutic problems with severe side effects, while dietary fibers as lipid lowering therapy are safer. Chitosan (CS) is a dietary fiber biodegradable, biocompatible and has many health benefits including wound healing, antiinflammatory, anti-cancers, immune-
 
16156 records 363/1078 page Previous Next First page 上5页 361362363364365 下5页 Last page